# Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant

Study · id `cardio:ct-nct03764241` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03764241](<https://clinicaltrials.gov/study/NCT03764241>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03764241

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.

## Technical summary

Registry record NCT03764241. Randomized; no masking; primary purpose treatment. Start 2020-02-01 (actual); primary completion 2022-03-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 280 participants (planned count; ClinicalTrials.gov record NCT03764241, source copy `cardio:ctgov-nct03764241-2023-06-01`, retrieved 2026-10-26)
- Started: 2020-02-01 (actual) (ClinicalTrials.gov record NCT03764241, source copy `cardio:ctgov-nct03764241-2023-06-01`, retrieved 2026-10-26)
- Primary completion: 2022-03-30 (actual) (ClinicalTrials.gov record NCT03764241, source copy `cardio:ctgov-nct03764241-2023-06-01`, retrieved 2026-10-26)
- Completion: 2023-12-30 (anticipated) (ClinicalTrials.gov record NCT03764241, source copy `cardio:ctgov-nct03764241-2023-06-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03764241, source copy `cardio:ctgov-nct03764241-2023-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03764241-2023-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
- Acronym: EARLYmyo-LVT
- Condition: ST Segment Elevation Myocardial Infarction
- Condition: Left Ventricular Thrombus
- Intervention (Drug): Rivaroxaban
- Intervention (Drug): Vitamin K Antagonist
- Lead sponsor: RenJi Hospital
- Lead sponsor class: OTHER
- Collaborator: Shanghai 6th People's Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Collaborator class: OTHER
- Collaborator: Shanghai Minhang Central Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai Songjiang Central Hospital
- Collaborator class: UNKNOWN
- Collaborator: Shanghai Fengxian District Central Hospital
- Collaborator class: OTHER
- Collaborator: Zhoushan Hospital in Zhejiang Province
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)
- Registry lists this organization as the lead sponsor: RenJi Hospital (`cardio:org-renji-hospital`)
- Registry lists this organization as a collaborator: Shanghai 6th People's Hospital (`cardio:org-shanghai-6th-people-s-hospital`)
- Registry lists this organization as a collaborator: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (`cardio:org-shanghai-ninth-people-s-hospital-affiliated-to-shanghai-d943b7`)

## Provenance

Content hash: 227d5464449c6cab65af0d5a2f5e9c8ce428be92b3b7fe71a6ce5b8b9c29ec26
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
